Release reagent for vitamin d compounds

a technology of vitamin d and reagents, which is applied in the field of reagent composition, can solve the problems of vitamin d having a relatively short biological half-life in the circulation, 25-hydroxyvitamin d or other vitamin d compounds to the vitamin d-binding protein enormously complicating the determination of vitamin d compounds, and all available methods for determining vitamin d

Inactive Publication Date: 2009-04-09
ROCHE DIAGNOSTICS OPERATIONS INC
View PDF2 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0016]The present invention concerns a reagent composition for releasing vitamin D compounds from vitamin D-binding protein which has a pH value of 3.8 to 4.8 and contains 5 to 30 volume percent of on

Problems solved by technology

In addition, vitamin D has a relatively short biological half-life in the circulation (24 hours), and it is therefore also for this reason not a suitable parameter for determining the vitamin D status of a patient.
The binding of 25-hydroxyvitamin D or other vitamin D compounds to the vitamin D-binding protein enormously complicates the determination of vitamin D compounds.
Despite immense efforts in recent years, a

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Release reagent for vitamin d compounds
  • Release reagent for vitamin d compounds
  • Release reagent for vitamin d compounds

Examples

Experimental program
Comparison scheme
Effect test

example 1

Synthesis of 25-Hydroxyvitamin D3-3-Hemisuccinate KLH

[0066]For this synthesis, 25-hydroxyvitamin D3 was chemically activated at position 3 (cf. Formula II) and coupled to KLH as an immunogen support. This synthesis was carried out via the intermediate steps 25-hydroxyvitamin D3-3-hemisuccinate and 25-hydroxyvitamin D3-3-hemisuccinate-N-hydroxysuccinimide ester.

[0067]1.1 Preparation of 25-Hydroxyvitamin D3-3-Hemisuccinate

[0068]10 mg (25 μmol) 25-hydroxyvitamin D2 (Sigma-Aldrich, No. H-4014) was dissolved in 1 ml absolute pyridine and stirred for 4 days at room temperature in the dark with 125 mg (1.25 mmol) succinic anhydride. The reaction mixture was taken up in 10 ml ethyl acetate and in each case washed with 2×10 ml water, 0.1 M hydrochloric acid and subsequently again with water. The organic phase was dried using about 1 g anhydrous sodium sulfate, filtered, and the solvent was removed in a vacuum. The residual solid was dried in a high vacuum. 10.5 mg (yield: 84%) of a colourles...

example 2

Generation and Isolation of Antibodies Against 25-Hydroxyvitamin D3

[0073]2.1 Immunization

[0074]The antibodies were generated in sheep. The 25-hydroxyvitamin D3-3-hemisuccinate KLH conjugate from Example 1 was used for the immunization. The immunization dosage was 0.1 mg per animal. The first immunization was carried out in complete Freund's adjuvant. Further immunizations took place at 4 week intervals in incomplete Freund's adjuvant for a period of 10 months. Serum was collected in the middle of each immunization interval.

[0075]2.2 Purification of the Polyclonal Sheep Antibodies

[0076]The lipid-containing components were removed from the serum of the sheep immunized with 25-hydroxyvitamin D3-3-hemisuccinate-LKH conjugate with the aid of AEROSIL (Evonik Degussa GmbH) (1.5%). Subsequently the immunoglobulins were precipitated using ammonium sulfate (1.7 M). The precipitate was dialyzed against 15 mM potassium phosphate buffer containing 50 mM NaCl, pH 7.0 and subsequently purified c...

example 3

Assays for the Detection of 25-Hydroxyvitamin D

[0100]Commercial assays were used according to the manufacturers' instructions. The 25-hydroxyvitamin D determinations were carried out by means of HPLC (test for 25(OH)vitamin D3, from the Immundiagnostik Company, Bensheim, order No. KC 3400) or by means of LC-MS-MS (Vogeser, M. et al., Clin. Chem. 50 (2004) 1415-1417) as described in the literature.

[0101]The preparation of the ingredients and the general test procedure for a new immunological test was described in the following:

[0102]3.1 Synthesis of Hydroxyvitamin D2-3-3′-N-(Hemisuberyl)Aminopropyl-Ether-Biotin-(Beta-Ala)-Glu-Glu-Lys(Epsilon) Conjugate (=Ag—Bi)

[0103]13.7 mg (25 μmol) hydroxyvitamin D2-3-3′-aminopropyl ether was dissolved in 3.5 ml DMSO, 28.7 mg (30 μmol) biotin-(beta-Ala)-Glu-Glu-Lys(cpison)-hemi-suberate-N-hydroxysuccinimide ester (Roche Applied Science, No. 11866656) and 12.5 μl triethylamine were added, and it was stirred overnight at room temperature. The reactio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Percent by volumeaaaaaaaaaa
Percent by volumeaaaaaaaaaa
Percent by volumeaaaaaaaaaa
Login to view more

Abstract

The present invention concerns a reagent composition for releasing vitamin D compounds bound to vitamin D-binding protein, a method for the detection of a 25-hydroxyvitamin D compound in which the 25-hydroxyvitamin D compound is released from vitamin D-binding protein using this reagent and the mixture obtained in this manner is analyzed, the use of the reagent to release vitamin D compounds as well as a kit for detecting 25-hydroxyvitamin D which contains the reagent for releasing vitamin D compounds in addition to the usual immunological reagents.

Description

RELATED APPLICATIONS[0001]This application is a continuation of PCT / EP2006 / 009361 filed Sep. 27, 2006 and claims priority to EP 05021246.3 filed Sep. 29, 2005.FIELD OF THE INVENTION[0002]The present invention concerns a reagent composition for releasing vitamin D compounds bound to vitamin D-binding protein and a method for detecting a 25-hydroxyvitamin D compound in which the 25-hydroxyvitamin D compound is released from the vitamin D-binding protein by the use of this reagent and the mixture obtained in this manner is analyzed. It also concerns the use of the reagent to release vitamin D compounds as well as a kit for detecting 25-hydroxyvitamin D which contains the reagent for releasing vitamin D compounds in addition to common immunological reagents.BACKGROUND[0003]An adequate supply of vitamin D is vital as the term “vitamin” already suggests. A deficiency of vitamin D leads to severe diseases such as rickets or osteoporosis. While vitamin D was still regarded as a single subst...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/59G01N33/566
CPCC07K16/44G01N33/82G01N33/52Y10T436/10G01N1/34
Inventor KYRIATSOULIS, APOSTOLOSFELDMANN, SUSANNEHUBER, ERAMUSHORN, NICOLEPROFF, LEOPOLD VON
Owner ROCHE DIAGNOSTICS OPERATIONS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap